ET
TEVA icon

Equitable Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Equitable Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
85,552
-343
-0.4% -$11.4K 0.12% 135
2026
Q1 		$2.59M Buy
+85,895
New +$2.76M 0.12% 139

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Equitable Trust's TEVA Position: Q2 2026 in Review

Equitable Trust reduced its Teva Pharmaceuticals (TEVA) stake by 0.4% in Q2 2026, selling an estimated $11.4K and leaving 85,552 shares worth $2.9M. The position accounts for 0.12% of the portfolio, ranked #135.

Equitable Trust first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 674 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Equitable Trust held 85,552 shares of Teva Pharmaceuticals worth $2.9M as of Q2 2026.
  • Equitable Trust sold 343 Teva Pharmaceuticals shares in Q2 2026, an estimated $11.4K.
  • Teva Pharmaceuticals made up 0.12% of Equitable Trust's portfolio in Q2 2026, its #135 holding.
  • Equitable Trust first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 674 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.